Annual EBIT
-$150.92 M
-$50.09 M-49.68%
December 1, 2024
Summary
- As of February 25, 2025, VKTX annual earnings before interest & taxes is -$150.92 million, with the most recent change of -$50.09 million (-49.68%) on December 1, 2024.
- During the last 3 years, VKTX annual EBIT has fallen by -$95.24 million (-171.04%).
- VKTX annual EBIT is now -123910.68% below its all-time high of -$121.70 thousand, reached on December 31, 2013.
Performance
VKTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$46.24 M
-$9.68 M-26.49%
December 1, 2024
Summary
- As of February 25, 2025, VKTX quarterly earnings before interest & taxes is -$46.24 million, with the most recent change of -$9.68 million (-26.49%) on December 1, 2024.
- Over the past year, VKTX quarterly EBIT has stayed the same.
- VKTX quarterly EBIT is now -2792.64% below its all-time high of $1.72 million, reached on December 31, 2014.
Performance
VKTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$150.92 M
-$16.95 M-12.65%
December 1, 2024
Summary
- As of February 25, 2025, VKTX TTM earnings before interest & taxes is -$150.92 million, with the most recent change of -$16.95 million (-12.65%) on December 1, 2024.
- Over the past year, VKTX TTM EBIT has stayed the same.
- VKTX TTM EBIT is now -137601.64% below its all-time high of -$109.60 thousand, reached on December 31, 2012.
Performance
VKTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
VKTX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -49.7% | 0.0% | 0.0% |
| 3 y3 years | -171.0% | -269.6% | -171.0% |
| 5 y5 years | -361.7% | -421.1% | -361.7% |
VKTX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -171.0% | at low | -269.6% | at low | -171.0% | at low |
| 5 y | 5-year | -361.7% | at low | -421.1% | at low | -361.7% | at low |
| alltime | all time | <-9999.0% | at low | -2792.6% | at low | <-9999.0% | at low |
Viking Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$150.92 M(+49.7%) | -$46.24 M(+26.5%) | -$150.92 M(+12.7%) |
| Sep 2024 | - | -$36.56 M(+7.3%) | -$133.97 M(+7.5%) |
| Jun 2024 | - | -$34.05 M(-0.1%) | -$124.68 M(+9.0%) |
| Mar 2024 | - | -$34.07 M(+16.3%) | -$114.36 M(+13.4%) |
| Dec 2023 | -$100.83 M(+43.3%) | -$29.29 M(+7.4%) | -$100.83 M(+9.8%) |
| Sep 2023 | - | -$27.27 M(+14.8%) | -$91.83 M(+13.7%) |
| Jun 2023 | - | -$23.74 M(+15.6%) | -$80.76 M(+8.2%) |
| Mar 2023 | - | -$20.54 M(+1.3%) | -$74.65 M(+6.1%) |
| Dec 2022 | -$70.36 M(+26.4%) | -$20.28 M(+25.2%) | -$70.36 M(+12.4%) |
| Sep 2022 | - | -$16.20 M(-8.1%) | -$62.58 M(+4.7%) |
| Jun 2022 | - | -$17.63 M(+8.5%) | -$59.79 M(+3.6%) |
| Mar 2022 | - | -$16.25 M(+29.9%) | -$57.70 M(+3.6%) |
| Dec 2021 | -$55.68 M(+30.5%) | -$12.51 M(-6.7%) | -$55.68 M(+2.3%) |
| Sep 2021 | - | -$13.40 M(-13.8%) | -$54.44 M(+7.0%) |
| Jun 2021 | - | -$15.54 M(+9.2%) | -$50.88 M(+13.3%) |
| Mar 2021 | - | -$14.23 M(+26.3%) | -$44.89 M(+7.9%) |
| Dec 2020 | -$42.66 M(+30.5%) | -$11.27 M(+14.5%) | -$41.61 M(+6.1%) |
| Sep 2020 | - | -$9.84 M(+3.0%) | -$39.22 M(+6.5%) |
| Jun 2020 | - | -$9.55 M(-12.8%) | -$36.81 M(-0.0%) |
| Mar 2020 | - | -$10.95 M(+23.4%) | -$36.83 M(+12.7%) |
| Dec 2019 | -$32.69 M(+50.9%) | -$8.87 M(+19.3%) | -$32.69 M(+12.5%) |
| Sep 2019 | - | -$7.44 M(-22.3%) | -$29.05 M(+3.0%) |
| Jun 2019 | - | -$9.57 M(+40.6%) | -$28.21 M(+12.1%) |
| Mar 2019 | - | -$6.81 M(+29.9%) | -$25.17 M(+16.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$21.66 M(+12.3%) | -$5.24 M(-20.6%) | -$21.66 M(+7.0%) |
| Sep 2018 | - | -$6.60 M(+1.1%) | -$20.25 M(+3.9%) |
| Jun 2018 | - | -$6.53 M(+98.2%) | -$19.49 M(+9.5%) |
| Mar 2018 | - | -$3.29 M(-14.0%) | -$17.80 M(-7.8%) |
| Dec 2017 | -$19.30 M(+49.3%) | -$3.83 M(-34.5%) | -$19.29 M(+3.3%) |
| Sep 2017 | - | -$5.84 M(+20.9%) | -$18.68 M(+15.2%) |
| Jun 2017 | - | -$4.83 M(+0.9%) | -$16.21 M(+11.5%) |
| Mar 2017 | - | -$4.79 M(+49.2%) | -$14.54 M(+12.5%) |
| Dec 2016 | -$12.92 M(-42.4%) | -$3.21 M(-4.9%) | -$12.92 M(-11.2%) |
| Sep 2016 | - | -$3.37 M(+6.6%) | -$14.55 M(-7.1%) |
| Jun 2016 | - | -$3.17 M(-0.2%) | -$15.66 M(-22.0%) |
| Mar 2016 | - | -$3.17 M(-34.4%) | -$20.09 M(-10.4%) |
| Dec 2015 | -$22.42 M(+5.5%) | -$4.84 M(+7.8%) | -$22.42 M(+41.3%) |
| Sep 2015 | - | -$4.49 M(-40.9%) | -$15.87 M(+38.9%) |
| Jun 2015 | - | -$7.59 M(+38.0%) | -$11.42 M(-57.0%) |
| Mar 2015 | - | -$5.50 M(-420.5%) | -$26.54 M(+24.9%) |
| Dec 2014 | -$21.26 M(>+9900.0%) | $1.72 M(-4382.3%) | -$21.26 M(-7.5%) |
| Sep 2014 | - | -$40.10 K(-99.8%) | -$22.97 M(+0.2%) |
| Jun 2014 | - | -$22.71 M(>+9900.0%) | -$22.93 M(+9576.2%) |
| Mar 2014 | - | -$220.00 K(+1194.1%) | -$237.00 K(+82.6%) |
| Dec 2013 | -$121.70 K | - | - |
| Jun 2013 | - | -$17.00 K(+431.3%) | -$129.80 K(+15.1%) |
| Mar 2013 | - | -$3200.00(-97.1%) | -$112.80 K(+2.9%) |
| Dec 2012 | - | -$109.60 K | -$109.60 K |
FAQ
- What is Viking Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Viking Therapeutics?
- What is Viking Therapeutics annual EBIT year-on-year change?
- What is Viking Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Viking Therapeutics?
- What is Viking Therapeutics quarterly EBIT year-on-year change?
- What is Viking Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Viking Therapeutics?
- What is Viking Therapeutics TTM EBIT year-on-year change?
What is Viking Therapeutics annual earnings before interest & taxes?
The current annual EBIT of VKTX is -$150.92 M
What is the all time high annual EBIT for Viking Therapeutics?
Viking Therapeutics all-time high annual earnings before interest & taxes is -$121.70 K
What is Viking Therapeutics annual EBIT year-on-year change?
Over the past year, VKTX annual earnings before interest & taxes has changed by -$50.09 M (-49.68%)
What is Viking Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of VKTX is -$46.24 M
What is the all time high quarterly EBIT for Viking Therapeutics?
Viking Therapeutics all-time high quarterly earnings before interest & taxes is $1.72 M
What is Viking Therapeutics quarterly EBIT year-on-year change?
Over the past year, VKTX quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is Viking Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of VKTX is -$150.92 M
What is the all time high TTM EBIT for Viking Therapeutics?
Viking Therapeutics all-time high TTM earnings before interest & taxes is -$109.60 K
What is Viking Therapeutics TTM EBIT year-on-year change?
Over the past year, VKTX TTM earnings before interest & taxes has changed by $0.00 (0.00%)